J. Shoblock

发表

Constitutively Active Mu Opioid Receptors Mediate the Enhanced Conditioned Aversive Effect of Naloxone in Morphine-Dependent Mice

N. Maidment, J. Shoblock, 2006, Neuropsychopharmacology.

In Vitro Pharmacological Characterization of RXFP3 Allosterism: An Example of Probe Dependency

P. Bonaventure, S. Sutton, M. Čík, 2012, PloS one.

Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia

P. Bonaventure, T. Lovenberg, N. Carruthers, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement

P. Bonaventure, T. Lovenberg, N. Carruthers, 2011, Psychopharmacology.

The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity.

J. Shoblock, 2007, CNS drug reviews.

In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

P. Bonaventure, C. Dvorak, T. Lovenberg, 2010, Psychopharmacology.

JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats

E. Levin, P. Bonaventure, T. Lovenberg, 2011, Psychopharmacology.

Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal

N. Maidment, J. Shoblock, 2007, Neuroscience.

Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats

S. D. Glick, I. M. Maisonneuve, J. Shoblock, 2003, Psychopharmacology.

The effects of thioperamide on extracellular levels of glutamate and GABA in the rat prefrontal cortex

Natalie Welty, J. Shoblock, 2009, Psychopharmacology.

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567

P. Bonaventure, T. Lovenberg, Hong Ao, 2013, British journal of pharmacology.

Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction

S. D. Glick, I. M. Maisonneuve, J. Shoblock, 2003, Psychopharmacology.

The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference

N. Maidment, J. Wichmann, J. Shoblock, 2005, Neuropharmacology.

In vivo Characterization of a Selective, Orally Available, and Brain Penetrant Small Molecule GPR139 Agonist

P. Bonaventure, T. Lovenberg, Changlu Liu, 2019, Front. Pharmacol..

Pharmacology of a Novel Central Nervous System–Penetrant P2X7 Antagonist JNJ-42253432

P. Bonaventure, T. Lovenberg, N. Carruthers, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice

N. Maidment, S. Narayanan, H. Lam, 2005, The European journal of neuroscience.

Pharmacological Blockade of Serotonin 5-HT7 Receptor Reverses Working Memory Deficits in Rats by Normalizing Cortical Glutamate Neurotransmission

Brian Lord, Leah Aluisio, Pascal Bonaventure, 2011, PloS one.

Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex

P. Bonaventure, T. Lovenberg, Tamara Berdyyeva, 2014, Front. Neurosci..

Differential Interactions of Desipramine with Amphetamine and Methamphetamine: Evidence that Amphetamine Releases Dopamine from Noradrenergic Neurons in the Medial Prefrontal Cortex

S. D. Glick, I. M. Maisonneuve, J. Shoblock, 2004, Neurochemical Research.